Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
Total Liabilities & Equity
Intersect Ent Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Total Liabilities & Equity
$127.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities & Equity
$54.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities & Equity
$36.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities & Equity
$39.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities & Equity
$72.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities & Equity
$15.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
See Also
What is Intersect Ent Inc's Total Liabilities & Equity?
Total Liabilities & Equity
127.4m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Total Liabilities & Equity amounts to 127.4m USD.
What is Intersect Ent Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
1%
Over the last year, the Total Liabilities & Equity growth was -39%. The average annual Total Liabilities & Equity growth rates for Intersect Ent Inc have been -3% over the past three years , 1% over the past five years .